Addicted to profit? Oxycontin dynasty pushed high doses of addictive painkiller as sales earned them $4BILLION - and wanted to cash in on NARCAN while 235,000 died of overdoses, claims lawsuit | WHAT REALLY HAPPENED


Addicted to profit? Oxycontin dynasty pushed high doses of addictive painkiller as sales earned them $4BILLION - and wanted to cash in on NARCAN while 235,000 died of overdoses, claims lawsuit

Oxycontin dynasty the Sacklers allegedly pushed high doses of the painkiller and hoped to cash in on anti-overdose drug NARCAN while 235,000 Americans died from the opoid epidemic, according to an unredacted complaint filed by the Commonwealth of Massachusetts.

The lawsuit claims that Purdue Pharma and members of the Sackler family knew that patients on higher dosages of OxyContin for long periods were at an increased risk of serious side effects, including addiction, yet they continued to promote the high doses as they yielded the most profit.

A copy of the filing obtained by DailyMail.com shows that from 2008 to 2016, the Sackler family added $4.2 billion to their already massive fortune in profits derived just from the sale of prescription opioids.

Richard Sackler, a son of a founder of Purdue Pharma and its former president, wrote in a 2008 email to company officials to 'measure our performance by Rx's by strength, giving higher measures to higher strengths', according to the filing.

Jonathan and Mortimer Sackler, were also copied in on the email, according to the new disclosures.

Richard Sackler has always denied he was involved in the company's marketing activities.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA